NDC 72162-1735-01 - Acyclovir
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 72162-1735
- Requested NDC
- 72162-1735-01
- Package NDCs from labels
- 72162-1735-1, 72162-1735-2, 72162-1735-3, 72162-1735-4, 72162-1735-5, 72162-1735-6, 72162-1735-7, 72162-1735-01
- Manufacturer
- Bryant Ranch Prepack
- Effective date
- 2024-09-06
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Acyclovir - Bryant Ranch Prepack | Bryant Ranch Prepack | 2024-09-06 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72162-1735-1 | Acyclovir | 120 in 1 BOTTLE, PLASTIC | TABLET | 120 | 102 | |
| 72162-1735-2 | Acyclovir | 20 in 1 BOTTLE, PLASTIC | TABLET | 20 | 102 | |
| 72162-1735-3 | Acyclovir | 30 in 1 BOTTLE, PLASTIC | TABLET | 30 | 102 | |
| 72162-1735-4 | Acyclovir | 28 in 1 BOTTLE, PLASTIC | TABLET | 28 | 102 | |
| 72162-1735-5 | Acyclovir | 10 in 1 BOTTLE, PLASTIC | TABLET | 10 | 102 | |
| 72162-1735-6 | Acyclovir | 60 in 1 BOTTLE, PLASTIC | TABLET | 60 | 102 | |
| 72162-1735-7 | Acyclovir | 50 in 1 BOTTLE, PLASTIC | TABLET | 50 | 102 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 72162-1735 | ACYCLOVIR TABLET [BRYANT RANCH PREPACK] | 102 | Current NDC, 7 package rows | 20240919_f09cdb3f-dfd2-4e47-bb5e-a5d26d8bcc89.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 72162-1735-1 | EA - Each | 72162-1735 | bf807b4a-bf13-47b0-92f0-62c6bc84e4db | 1 | 2023-10-16 |
| 72162-1735-2 | EA - Each | 72162-1735 | 999a483e-5326-4ee8-87e6-8fd123c683a9 | 1 | 2023-10-16 |
| 72162-1735-3 | EA - Each | 72162-1735 | 38ad4994-e407-46b8-9f2b-ed6e1e7914bc | 1 | 2023-10-16 |
| 72162-1735-4 | EA - Each | 72162-1735 | 60b855ee-7970-4008-a5fb-103c4ae7ea3a | 1 | 2023-10-16 |
| 72162-1735-5 | EA - Each | 72162-1735 | 44fa26cf-3c82-408f-a845-49cec7cb696a | 1 | 2023-10-16 |
| 72162-1735-6 | EA - Each | 72162-1735 | b231becf-f4b5-4705-8b28-6f8972065e5c | 1 | 2023-10-16 |
| 72162-1735-7 | EA - Each | 72162-1735 | a8a2b11d-7516-4dab-bb64-cf00cb211cf7 | 1 | 2023-10-16 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Acyclovir | ACYCLOVIR | NuCare Pharmaceuticals,Inc. | c2d9940a-ce88-5fd0-e053-2a95a90a4bc8 | 2026-03-26 | Warnings, Adverse reactions | ANDA075382 197313 X4HES1O11F |
| Acyclovir | ACYCLOVIR | Avet Pharmaceuticals Inc. | 4d5b5fd7-64ab-8275-e063-6394a90a2205 | 2026-03-25 | Warnings, Adverse reactions | X4HES1O11F |
| ACYCLOVIR | ACYCLOVIR | Bryant Ranch Prepack | e5356160-cb35-4ff6-91d5-2ade594e0279 | 2026-03-25 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | Bryant Ranch Prepack | 69e5455e-d0be-4c2b-b9ab-458b5480ed57 | 2026-03-16 | Warnings, Adverse reactions | 197311 X4HES1O11F |
| acyclovir | ACYCLOVIR | REMEDYREPACK INC. | 8fdabab2-bc93-48ab-9c13-d22ec90fdcfc | 2026-02-27 | Warnings, Adverse reactions | 197311 X4HES1O11F |
| Acyclovir | ACYCLOVIR | Florida Pharmaceutical Products, LLC | 3df7fa38-a869-45fb-98a3-81c5a2527d62 | 2026-02-18 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | Major Pharmaceuticals | 46150f19-ce5d-42a0-80a7-f96fda2b9879 | 2026-02-18 | Warnings, Adverse reactions | 197311 X4HES1O11F |
| Acyclovir | ACYCLOVIR | Preferred Pharmaceuticals, Inc. | b6d69697-12bb-4548-a6c3-2463cbf54f8f | 2026-02-11 | Warnings, Adverse reactions | 197313 X4HES1O11F |
| Acyclovir | ACYCLOVIR | A-S Medication Solutions | 2e6a3667-af06-40de-80c0-8c4346e0671f | 2026-02-08 | Warnings, Adverse reactions | 197313 X4HES1O11F |
| Acyclovir | ACYCLOVIR | Camber Pharmaceuticals, Inc. | 0910335b-6796-459f-b97e-d7ef5439a060 | 2026-02-02 | Warnings, Adverse reactions | 197313 197311 X4HES1O11F |
| acyclovir | ACYCLOVIR | Glenmark Pharmaceuticals Inc., USA | 149f4418-7668-4d34-a6f9-69bf3a9c5049 | 2026-01-28 | Warnings, Adverse reactions | X4HES1O11F |
| acyclovir | ACYCLOVIR | ANI Pharmaceuticals, Inc. | 8208711c-18ba-4615-b932-3c0bb7e6efae | 2026-01-23 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | Actavis Pharma, Inc. | a4c1305c-f18c-4fb0-83d8-2822341f2dfa | 2026-01-21 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | Preferred Pharmaceuticals Inc | 75334fc5-d236-401a-875c-f4f9c7749c1a | 2026-01-19 | Warnings, Adverse reactions | 197311 X4HES1O11F |
| Lotrimin Daily Sweat and Odor Control | TOPICAL STARCH | Bayer HealthCare LLC. | 9ec5c80d-b550-496f-e053-2a95a90a5489 | 2026-01-16 | Warnings | O8232NY3SJ |
| acyclovir | ACYCLOVIR | Preferred Pharmaceuticals Inc | c11c1136-7421-48ff-86d2-39507e80a04c | 2026-01-15 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | Preferred Pharmaceuticals Inc. | b1033fda-8242-4006-b1cd-23474d70671f | 2026-01-15 | Warnings, Adverse reactions | 197311 X4HES1O11F |
| Acyclovir | ACYCLOVIR | AvPAK | 6e203fa9-ee97-1e08-8d6a-fb57cfa13e19 | 2026-01-08 | Warnings, Adverse reactions | ANDA075382 197313 197311 X4HES1O11F |
| Acyclovir | ACYCLOVIR | Cadila Pharmaceuticals Limited | dbaf4bf5-57e3-4770-a9b2-d47649e54c1b | 2026-01-02 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | Northwind Health Company, LLC | 5dcfd21c-43f0-469c-be70-a4e74e6ccf88 | 2026-01-01 | Warnings, Adverse reactions | 197311 X4HES1O11F |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.